https://www.selleckchem.com/products/me-401.html
In the overall population, the adjusted OR of the primary endpoint associated with an hs-CRP value ≥ 2mg/L was 2.10 (95% CI 1.46-3.0. For the same risk, hs-CRP was 7 and 2mg/L in patients with and without DM. A similar behavior was observed for the secondary endpoint when the HR associated with an hs-CRP value ≥ 2mg/L found in the overall population was 2.25 (95% CI 1.57-3.22). For the same risk, hs-CRP was 8 and 1.5mg/L in DM and non-DM patients. This study shows that hs-CRP predicts in-hospital outcome and two-year mortality in AMI p